Startup Valuation Services in India

Business valuation services start from ₹35,000 for pre-revenue startup company valuation, ₹50,000 for growth-stage company valuation analysis, and ₹1,00,000 for multi-framework registered valuer reports covering FEMA, Rule 11UA, and 409A. Fixed-fee quotes are provided after a free 30-minute consultation. Call +91 99622 60333 or WhatsApp for a same-day quote.

Valuations required by the Companies Act, 2013 (section 247 — preferential allotments, ESOP pricing, mergers, sweat equity) and by the IBC must be issued by an IBBI Registered Valuer under the Companies (Registered Valuers and Valuation) Rules, 2017; FEMA pricing certificates may be issued by a Chartered Accountant, SEBI-registered merchant banker or Cost Accountant, and the income-tax rules name a merchant banker for Rule 11UA (DCF) and Rule 15 (ESOP perquisite) valuations. CA V. Viswanathan holds registration IBBI/RV/03/2019/12333 and provides registered valuer services legally valid for Companies Act, FEMA, Income Tax, IBC, and SEBI purposes. Reports from unregistered valuers are not accepted by regulators.

Startup company valuation is the process of determining the fair market value of an early-stage or growth-stage company for fundraising, ESOP allocation, FEMA/FDI compliance, Rule 11UA tax filings, or M&A. Methods vary by stage — Berkus, Scorecard, and VC Method for pre-revenue; DCF, Comparable Company Analysis, and Monte Carlo simulation for growth-stage startups.

Yes. Business valuation for startups — especially pre-revenue — uses qualitative and probability-based methods (Berkus, Scorecard, VC Method) because historical revenues don't exist. Company valuation for established businesses relies more on DCF, EBITDA multiples, and comparable transactions. Virtual Auditor applies all 18 methods as appropriate to the stage and regulatory requirement.

A standard company valuation analysis takes 5–7 working days from complete data receipt. Express delivery in 2–3 days is available for urgent regulatory filings at a premium. Pre-revenue startup company valuation typically completes in 3–5 days.

Yes — this is a core specialisation. We use Berkus Method, Scorecard Method, Venture Capital Method, and our proprietary Revenue Ramp Bayesian Estimation for pre-revenue companies. These methods are specifically designed for startups where traditional DCF is unreliable. The resulting report is accepted under Rule 11UA and FEMA.

It depends on the basis of investment. NRI investment on a repatriation basis is treated like foreign direct investment: the price must not be below fair value, certified by a Chartered Accountant, a SEBI-registered Merchant Banker or a practising Cost Accountant. NRI investment on a non-repatriation basis is treated as domestic investment (Schedule IV of the NDI Rules, 2019), so the FEMA pricing rules do not apply, but a registered valuer’s report is still needed under the Companies Act for a preferential allotment. We assess the applicable framework at no charge during the initial consultation.

Typically: last 3 years audited financials, MCA filings, cap table, financial projections (3–5 years), term sheet or investment documents (if any), business plan, list of IP/assets, and comparable company data if available. We send a structured checklist after the initial consultation. For pre-revenue startups, financials may not be required.

Yes. We use Berkus Method, Scorecard Method, Venture Capital Method, and Revenue Ramp Bayesian Estimation for pre-revenue companies.

NRI investment on a repatriation basis is treated like foreign direct investment: the price must not be below fair value, certified by a Chartered Accountant, a SEBI-registered Merchant Banker or a practising Cost Accountant. We assess the applicable framework at no charge during the initial consultation.

Yes. A private company issuing shares or convertible securities on a preferential basis must price them on a valuation report from an IBBI Registered Valuer (Section 62(1)(c) of the Companies Act, 2013 read with Rule 13 of the Companies (Share Capital and Debentures) Rules, 2014), with the offer made as a private placement under Section 42. A plain CA valuation certificate does not meet this requirement. If the investor is a non-resident, a FEMA pricing certificate is also needed. CA V. Viswanathan signs these reports as an IBBI Registered Valuer (IBBI/RV/03/2019/12333).

It depends on the purpose. Preferential allotment to investors: an IBBI Registered Valuer’s report (Companies Act, Section 62(1)(c) and Rule 13). Foreign investor: a FEMA pricing certificate from a Chartered Accountant in practice, a SEBI-registered merchant banker or a practising cost accountant (RBI Master Direction – Foreign Investment, para 8). Income tax: angel tax does not apply to share issues from assessment year 2025-26, but shares received below fair market value are still taxed in the recipient’s hands under Section 56(2)(x). ESOPs: an Ind AS 102 option value at grant and, for employee tax on exercise of unlisted shares, a merchant banker’s value. Investor negotiation: no statutory format; the price is what the parties agree, supported by the methods investors use.

Start with the purpose, because it fixes the report and the signatory: a Registered Valuer’s report for a preferential allotment, a FEMA certificate for a foreign investor, or an advisory value for negotiation. Then match the method to the stage: before revenue, scorecard or Berkus methods, the venture-capital method, or a backsolve from a recent priced round; with revenue, a DCF with scenarios cross-checked against revenue multiples of comparable companies; later, DCF and market methods together. Then reflect the instrument: preference shares, convertible notes or SAFEs need an option-pricing or waterfall allocation, and for foreign investors the conversion price or formula must be fixed upfront. The evidence is financial statements, projections with their assumptions, the cap table and term sheet, and recent rounds. The report states why each method was chosen and how sensitive the value is to the key assumptions.